Functional analysis of human papillomavirus type 16 E7 by complementation with adenovirus E1A mutants

Area of Science:

• Oncology
• Virology
• Molecular Biology

Background:

• Human papillomavirus type 16 (HPV16) is a major cause of cervical cancer.
• The HPV16 E7 oncoprotein targets the retinoblastoma tumor suppressor protein (RB).
• Adenovirus E1A proteins also interact with RB and other cellular factors.

Purpose of the Study:

• To investigate the functional equivalence between HPV16 E7 and Adenovirus E1A proteins.
• To determine the role of the RB-binding domain in E7 function.
• To explore potential interactions beyond RB binding for both proteins.

Main Methods:

• Complementation assays were performed using HPV16 E7 mutants and Adenovirus E1A mutants in baby rat kidney cells.
• Analysis focused on the ability of E7 mutants to substitute for E1A functions, particularly RB binding and p300 interaction.
• Mutational analysis of the RB-binding region of E7 was conducted.

Main Results:

• The RB-binding region of HPV16 E7 could functionally substitute for the corresponding region in Adenovirus E1A.
• An N-terminal E7 mutant showed functional equivalence to an E1A mutant defective in p300 binding.
• Mutations within the E7 RB-binding region impaired complementation with both p300-binding deficient E1A and N-terminal E7 mutants.

Conclusions:

• The RB-binding domain of HPV16 E7 plays a crucial role in complementing E1A functions.
• Functional equivalence between E7 and E1A extends beyond RB binding, potentially involving interactions with co-activators like p300.
• Mutations in the E7 RB-binding region may disrupt multiple protein-protein interactions essential for its oncogenic activity.